Gong, W., Taner, H. F., Wu, Y., He, Y., Zhou, X., Li, Z., Hu, X., Ursin, C., Debnath, K. C., Okuyama, K., Hu, Q., Donnelly, C. R., Nor, F., Perera, C. D., Bellile, E., Yunesi, A., Zhai, Z., Zhao, M., Cheng, W., Fitzsimonds, Z. R., Broses, L., Li, J., Demehri, S., Nagrath, D., Wolf, G. T., Sikora, A. G., Yu, Y., Wen, H., Wei, L., Chinn, S. B., Myers, J. N., Akira, S., Xie, Y., Moon, J. J., Lei, Y. L. (2025). BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity. Nature Communications. https://doi.org/10.1038/s41467-025-68027-2